Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Nanogen Reports 2003 Fourth Quarter and Year-End

February 18th, 2004

Nanogen Reports 2003 Fourth Quarter and Year-End

Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer of molecular diagnostic products, today announced its financial results for the fourth quarter and year ended December 31, 2003. Total revenues for the quarter ended December 31, 2003 were $2.1 million compared to $1.7 million in the third quarter of 2003 and $12.1 million in the fourth quarter of 2002. Fourth quarter product revenue increased by 45% over the prior quarter on the basis of eight new instrument sales and one reagent rental.

Source:
PRNewswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project